Church & Dwight Co. (NYSE: CHD) has slipped about 12% over the past year as consumers cut back and input costs remained elevated. The stock trades near $88/share, well below its 52-week high of $116.
Recently, in Q2 2025, Church & Dwight’s results were essentially flat. Net sales declined 0.3% year over year and organic sales were roughly unchanged. Adjusted gross margin was 45.0%, down about 40 basis points as higher manufacturing costs and tariffs offset productivity gains. Management reiterated its focus on automation and cost efficiency to support profitability and cash flow.
This article explores where Wall Street analysts think Church & Dwight could trade by 2027. We have pulled together consensus targets and valuation models to outline the stock’s potential path. These figures reflect current analyst expectations and are not TIKR’s own predictions.
Unlock our Free Report: 5 AI compounders that analysts believe are undervalued and could deliver years of outperformance with accelerating AI adoption (Sign up for TIKR, it’s free) >>>
Analyst Price Targets Suggest Modest Upside
CHD trades at about $88/share today. The average analyst price target is $98/share, implying roughly 12% upside over the next year. Forecasts remain fairly tight, reflecting cautious sentiment across Wall Street:
- High estimate: ~$115/share
- Low estimate: ~$73/share
- Median target: ~$100/share
- Ratings: 8 Buys, 1 Outperform, 9 Holds, 3 Underperforms, 3 Sells
Since upside is in the 10–15% range, analysts see moderate potential for gains. For investors, CHD could outperform if cost efficiencies and margin improvements continue, but the stock is not viewed as deeply undervalued.
See analysts’ growth forecasts and price targets for Church & Dwight (It’s free!) >>>
Church & Dwight: Growth Outlook and Valuation
The company’s fundamentals appear steady, though not particularly strong:
- Revenue is projected to grow ~2.8% annually through 2027
- Operating margins are expected to remain near ~19.6%
- Shares trade at ~24.5x forward earnings, slightly above peers
- Based on analysts’ average estimates, TIKR’s Guided Valuation Model using a fair forward P/E suggests ~$103/share by 2027
- That implies about 17% total upside, or roughly 7% annualized returns
For investors, these figures point to consistent but modest compounding. The stock’s valuation premium reflects its reliability, making CHD a stable defensive play rather than a high-growth opportunity.
Value stocks like Church & Dwight in as little as 60 seconds with TIKR (It’s free) >>>
What’s Driving the Optimism?
Church & Dwight’s portfolio of household and personal care brands continues to generate dependable earnings through shifting market conditions. Products like Arm & Hammer, OxiClean, and Waterpik remain category leaders, backed by strong consumer loyalty.
Margins have improved as cost pressures ease, and management’s focus on automation and efficiency is helping offset slower volume growth. Cash flow generation remains solid, supporting reinvestment and shareholder returns.
For investors, these strengths suggest CHD is a steady performer with the tools to protect profitability and gradually rebuild earnings momentum.
Bear Case: Limited Growth and Valuation Risk
Even with these positives, CHD’s growth outlook remains subdued. Analysts expect less than 3% annual revenue growth through 2027, which limits earnings momentum. The stock’s valuation near 25x forward earnings also looks demanding for a slow-growth consumer staples name.
Competition remains intense, especially from private-label and discount brands. If inflation reaccelerates or consumers keep trading down, Church & Dwight’s margins could flatten.
For investors, the main risk is that the company’s dependable fundamentals are already priced in, leaving little room for meaningful upside unless it consistently outperforms expectations.
Outlook for 2027: What Could CHD Be Worth?
Based on analysts’ average estimates, TIKR’s Guided Valuation Model suggests CHD could trade near $103/share by 2027. That represents roughly 17% total upside, or about 7% annualized returns from current levels.
While that marks a steady recovery, the projection already assumes gradual margin expansion and disciplined cost control. For stronger upside, the company would need faster organic growth or greater share gains across key product categories.
For investors, CHD looks like a dependable compounder, resilient, cash-generative, and defensive, but unlikely to deliver outsized returns without an unexpected boost in growth.
AI Compounders With Massive Upside That Wall Street Is Overlooking
Everyone wants to cash in on AI. But while the crowd chases the obvious names benefiting from AI like NVIDIA, AMD, or Taiwan Semiconductor, the real opportunity may lie on the AI application layer where a handful of compounders are quietly embedding AI into products people already use every day.
TIKR just released a new free report on 5 undervalued compounders that analysts believe could deliver years of outperformance as AI adoption accelerates.
Inside the report, you’ll find:
- Businesses already turning AI into revenue and earnings growth
- Stocks trading below fair value despite strong analyst forecasts
- Unique picks most investors haven’t even considered
If you want to catch the next wave of AI winners, this report is a must-read.
Click here to sign up for TIKR and get your free copy of TIKR’s 5 AI Compounders report today.